ABT · News · 20261022N

Competition and Market Position

ABBOTT LABORATORIES · 2026-10-22 · Importance 17 · Surprise 24

A 172-patient peer-reviewed study compared Catheter Precision’s LockeT suture-retention device with Abbott’s Perclose internal vascular closure device after large-bore venous access. The study covered electrophysiologic procedures and reported superior safety and efficacy for LockeT versus Perclose. The findings indicate competitive pressure for Abbott in vascular closure devices used in electrophysiology and related interventional procedures.

Key facts

• Management addressed competitive pressures in diabetes care on the third-quarter 2026 earnings call. source
• Perclose is described as a leading internal vascular closure device manufactured and sold by Abbott. source